# The Medicines (Products for Human Use) (Fees) Regulations 2016, Paragraph 26: Fees where person holds clinical trial certificate


Where a major application is made by a person who holds a clinical trial certificate for a medicinal product which contains the same active ingredient as the medicinal product in respect of which the marketing authorisation is applied for, the fee payable under regulation 12(1)(a) in connection with the application is reduced by the amount of the application fee paid for the clinical trial certificate.

---
Source: https://www.legislation.gov.uk/uksi/2016/190/schedule/2/paragraph/26 (the official version)
Page: https://openlegislation.uk/medicines-products-for-human-use-fees-regulations-2016/schedule-2/paragraph-26
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.